AI-Generated Health Messages for Outpatient Care
(AI-CARE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if AI-generated health messages can effectively support primary care by providing accurate and accessible patient education. By comparing messages created by AI and human experts, the researchers hope to discover if AI can help reduce misinformation and improve communication between patients and healthcare providers. The trial will assess the quality and usefulness of these messages, particularly considering how different economic backgrounds might affect their accessibility. Individuals who speak English or French and can provide feedback on these messages might be suitable for this trial. As an unphased trial, this study offers participants the opportunity to contribute to innovative research that could enhance healthcare communication for diverse communities.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems to focus on evaluating health messages rather than medical treatments.
What prior data suggests that AI-generated health messages are safe for patient education?
Research has shown that AI-generated health messages offer both benefits and drawbacks. Some studies found that these messages can speed up communication with patients. However, safety concerns exist. AI might sometimes provide outdated or incorrect information, potentially confusing patients or causing misunderstandings about their health.
Another risk is that AI might miss important health signs due to biases in the data it learned from, potentially overlooking serious health problems.
While AI holds exciting potential to assist doctors and nurses, awareness of these risks is crucial. Always verify AI-generated advice with a healthcare professional to ensure accuracy and safety.12345Why are researchers excited about this trial?
Researchers are excited about the trial of AI-generated health messages for outpatient care because it introduces a novel approach to patient communication. Unlike traditional methods where health messages are crafted by human experts, this approach uses Artificial Intelligence to generate personalized messages. This method could potentially enhance patient engagement by providing more tailored and frequent communication. The trial aims to explore whether AI can match or even surpass human expertise in delivering effective health promotional messages, potentially transforming how outpatient care is managed.
What evidence suggests that AI-generated health messages are effective for patient education?
This trial will compare AI-generated health messages with those created by human experts. Research has shown that AI-generated health messages could transform communication in healthcare. AI can facilitate clearer and quicker interactions between doctors and patients. Studies have found that AI reduces the time needed to reply to patient messages by nearly 7%, allowing doctors to answer more questions without additional time. Researchers are also exploring AI tools for their ability to create high-quality information that meets primary care standards. Early evidence suggests AI might reduce misinformation and enhance patient education.36789
Who Is on the Research Team?
William Hogg, MD, MSc
Principal Investigator
Institut du Savoir Montfort
Sharon Johnston, MD, LLM
Principal Investigator
Institut du Savoir Montfort
Are You a Good Fit for This Trial?
This trial is for individuals who can visit outpatient clinics and are interested in evaluating health promotional messages. Participants will be involved in reviewing the quality of information provided by both AI-generated and human-created health messages.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Content Generation and Evaluation
Generative AI and human experts create patient education messages. Review panels assess the messages on quality, adaptability, and relevance.
Follow-up
Participants are monitored for feedback on message effectiveness and quality
What Are the Treatments Tested in This Trial?
Interventions
- Health promotional messages generated by Artificial Intelligence
Find a Clinic Near You
Who Is Running the Clinical Trial?
Hopital Montfort
Lead Sponsor
Cheo Research Institute
Collaborator
CHEO Research Institute
Collaborator
Eastern Ontario Health Unit
Collaborator